Lori A. Woods
At a glance: Lori A. Woods is Director at Perspective Therapeutics (CATX). Their latest SEC Form 4, filed Nov 16, 2026, reported a purchase of $20K. On file: 1 purchase line ($20K) and 0 sale lines ($0).
Disclosed holdings: about $21K of CATX stock: 28,557 shares reported on their latest Form 4 (filed Nov 16, 2026), valued at the Nov 20, 2026 close of $0.75. This counts only CATX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Perspective Therapeutics, Inc. (CATX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Lori A. Woods's InsiderPrint
9 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $34K a trade.
- Bump outward: a purchase (9)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Kevin M. CharltonDirector · EVLV · 99% match
- Thane WettigCEO · KYNB · 99% match
- William WesemannDirector · ACON · 99% match
- Eric R. NewellCFO · EGBN · 99% match
- David A. PeacockCEO · ADV · 99% matchTheir buys since 2023: 6 of 12 beat the S&P 500
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2023
From the SEC's insider data sets: each open-market buy by Lori A. Woods, matched to how the stock did over the next 90 days against the S&P 500.
3 of 3 buys beat the S&P 500 (100%), median +32.4% vs. the index. Small sample: treat with care. All insider buys: 46%.
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 16SEC | CATXPerspective Therapeutics, Inc.Off-schedule buyStake +494%Past buys 3/3 beat S&P | Buy | 23,75028,557 held (+494%) | $0.84 | $20K | -11.5% |
- Buy
Director Lori A Woods bought $20K of CATX at $0.84 — first open-market purchase in our records; raises the stake by 494%.
Follow Lori A. Woods
Get one email when Lori A. Woods files a new purchase or sale. Free.
At most one email a day about Lori A. Woods, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.